What is Illumina's stock-based comp?

Illumina (ILMN) reported stock-based comp of $60M in Q1 2026.

How has Illumina's stock-based comp changed year-over-year?

Illumina's stock-based comp decreased by 17.8% year-over-year, from $73M to $60M.

What is the long-term trend for Illumina's stock-based comp?

Over 4 years (2021 to 2025), Illumina's stock-based comp has grown at a -22.3% compound annual growth rate (CAGR), from $754M to $275M.

Illumina ILMN Stock-Based Comp

Stock-Based Comp at other companies

RevvityRVTY

——

Thermo Fisher ScientificTMO

——

Pacific Biosciences of CaliforniaPACB

——

Fulgent Genetics, Inc.FLGT

——

Other financials

Income statement

See full

Revenue$1.1B+4.8%

Gross profit$721.0M+5.6%

Operating income$209.0M+27.4%

Net income$134.0M+2.3%

EPS (diluted)$0.87+6.1%

Balance sheet

See full

Cash & equivalents$1.1B-2.2%

Total debt$2.0B-3.0%

Total equity$2.7B+13.0%

Total assets$6.6B+6.1%

Cash flow

See full

Operating cash flow$289.0M+20.4%

CapEx$38.0M+18.8%

Free cash flow$251.0M+20.7%

Valuation

See full

Market cap$29.2B+69.7%

Enterprise value$30.15B+64.1%

P/E34.2×+20.5×

P/S6.7×+2.6×

Profitability

See full

Gross margin66.2%-0.1pp

Operating margin19.4%—

Net margin19.4%+12.7pp

FCF margin22.2%+2.0pp

Returns & leverage

See full

Return on equity33.8%+23.9pp

Debt / equity0.8×-0.1×

Current ratio1.7×-0.1×

Where this comes from

Reported directly by Illumina in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Illumina’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Illumina's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Illumina's stock-based comp?: Illumina (ILMN) reported stock-based comp of $60M in Q1 2026.
How has Illumina's stock-based comp changed year-over-year?: Illumina's stock-based comp decreased by 17.8% year-over-year, from $73M to $60M.
What is the long-term trend for Illumina's stock-based comp?: Over 4 years (2021 to 2025), Illumina's stock-based comp has grown at a -22.3% compound annual growth rate (CAGR), from $754M to $275M.